TITLE

The association between elevated levels of inflammation biomarkers and coronary artery disease and death

AUTHOR(S)
Lowe, Gordon D. O.
PUB. DATE
February 2006
SOURCE
CMAJ: Canadian Medical Association Journal;2/14/2006, Vol. 174 Issue 4, p479
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
The section comments on the article "Relative Value of Multiple Plasma Biomarkers as Risk Factors for Coronary Artery Disease and Death in an Angiography Cohort," by Kenny W. J. Lee, et al, which appeared in the 2006 issue of the "Canadian Medical Association Journal." The strong points and weaknesses of the article are identified.
ACCESSION #
19777034

 

Related Articles

  • Relative value of multiple plasma biomarkers as risk factors for coronary artery disease and death in an angiography cohort. Lee, Kenney W. J.; Hill, John S.; Walley, Keith R.; Frohlich, Jiri J. // CMAJ: Canadian Medical Association Journal;2/14/2006, Vol. 174 Issue 4, p461 

    Background: Although elevated levels of C-reactive protein (CRP), interleukin (IL)-6, serum amyloid A protein (SAA) and total homocysteine (tHcy) have been associated with the increased likelihood of cardiovascular events, the relative or combined utility of these biomarkers in predicting...

  • The Missed MI: Understanding the Limits of Biomarkers and CT Angiography. Hals, Gary; LoVecchio, Frank // Emergency Medicine Reports;6/22/2009, Vol. 30 Issue 14, p173 

    • Serial cardiac biomarkers over 9 to 12 hours remain the gold standard, but shorter sampling intervals and single measures are appropriate in selected patients. • Chest pain units remain the most realistic approach to reducing the rate of missed MIs. • ACS risk score...

  • Homocysteine in Angiographically Proven Coronary Disease. Halilovic, Enes; Kabil, Emir; Ljuca, Farid; Nuhbegovic, Sabina // Medicinski Arhiv;2009, Vol. 63 Issue 5, p256 

    The research included 200 subjects, of which 150 had angiographically proven coronary disease with the coronary artery stenosis of 50% or more, and 50 subjects who did not have angiographically proven coronary disease. Patients were chosen randomly out of approximately 1000 patients who...

  • Homocysteine Level and Coronary Artery Disease. Kazemi, M. B. Sharif; Eshraghian, K.; Omrani, G. R.; Lankarani, K. Bagheri; Hosseini, E. // Angiology;Jan/Feb2006, Vol. 57 Issue 1, p9 

    Atherosclerosis, and its most common manifestation, coronary artery disease (CAD), are rather common causes of morbidity and mortality worldwide. Recognition of its various risk factors is important to planning effective preventive measures. After the homocysteine theory was presented in 1969,...

  • An alternative marker of low-density lipoprotein cholesterol in coronary artery disease: non-high-density lipoprotein cholesterol. ERCAN, Müjgan; OĞUZ, Esra; YILMAZ, Fatma Meriç; BOĞDAYCIOĞLU, Nihal; ÜNAL, Kübranur; ŞAHİN, Deniz; UYSAL, Sema // Turkish Journal of Medical Sciences;2015, Vol. 45 Issue 1, p153 

    Background/aim: Dyslipidemia is one of the most important risk factors for coronary artery disease (CAD), and low-density lipoprotein cholesterol (LDL-C) is used to measure dyslipidemia. Non-high-density lipoprotein cholesterol (non-HDL-C) seems to be an alternative parameter to LDL-C as it is...

  • POTENTIAL ROLE OF SELECTED BIOMARKERS FOR PREDICTING THE PRESENCE AND EXTENT OF CORONARY ARTERY DISEASE.  // Biomedical Papers of the Medical Faculty of Palacky University i;2010, Vol. 154 Issue 3, p219 

    No abstract available.

  • P724 Association of biochemical markers with long-term outcomes in patients after coronary angioplasty and stenting. Musikhina, NA; Petelina, TI; Gapon, LI; Kuznetsov, VA; Takkand, AG; Osipova // Cardiovascular Research;Jul2014, Vol. 103 Issue suppl_1, pS132 

    Purpose: To perform a prospective comparative analysis of lipid profiles, markers for inflammation and endothelial dysfunction in groups of coronary artery disease (CAD) patients with and without episodes of unstable coronary blood flow after percutaneous coronary intervention (PCI); and to...

  • Signature of Circulating MicroRNAs as Potential Biomarkers in Vulnerable Coronary Artery Disease. Ren, Jingyi; Zhang, Jing; Xu, Ning; Han, Guanping; Geng, Qiang; Song, Junxian; Li, Sufang; Zhao, Jianqing; Chen, Hong // PLoS ONE;Dec2013, Vol. 8 Issue 12, p1 

    Aims: MicroRNAs (miRNAs) play important roles in the pathogenesis of cardiovascular diseases. Circulating miRNAs were recently identified as biomarkers for various physiological and pathological conditions. In this study, we aimed to identify the circulating miRNA fingerprint of vulnerable...

  • Role of Novel Biomarkers of Inflammation in Patients With Stable Coronary Heart Disease. Oren, Hüseyin; Erbay, Ali R.; Balcı, Mustafa; Çehreli, Sengül // Angiology;Apr/May2007, Vol. 58 Issue 2, p148 

    Atherosclerosis is a dynamic chronic inflammatory process, and some inflammatory biomarkers have roles in this process. The levels of C-reactive protein (CRP) in patients with chronic stable coronary heart disease (CHD) have not been investigated well, and the levels of macrophage...

Share

Read the Article

Courtesy of VIRGINIA BEACH PUBLIC LIBRARY AND SYSTEM

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics